Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival

BACKGROUND: Resistance to temozolomide (TMZ) is due in part to enhanced DNA repair mediated by high expression of O(6)-methyl guanine DNA methyltransferase (MGMT) that is often characterised by unmethylated promoter. Here, we investigated pre-treatment of glioblastoma (GBM) cells with the 26S-protea...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Mohummad Aminur, Gras Navarro, Andrea, Brekke, Jorunn, Engelsen, Agnete, Bindesbøll, Christian, Sarowar, Shahin, Bahador, Marzieh, Bifulco, Ersilia, Goplen, Dorota, Waha, Andreas, Lie, Stein Atle, Gjertsen, Bjørn Tore, Selheim, Frode, Enger, Per Øyvind, Simonsen, Anne, Chekenya, Martha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888814/
https://www.ncbi.nlm.nih.gov/pubmed/31413318
http://dx.doi.org/10.1038/s41416-019-0551-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888814/
https://www.ncbi.nlm.nih.gov/pubmed/31413318
http://dx.doi.org/10.1038/s41416-019-0551-1

Ejemplares similares